| Description of Property | Date Acquired | Cost or Other Basis | Prior Years' Depreciation | Computation Method | Rate / Life (# of years) |
Current Year's Depreciation Expense | Net Investment Income | Adjusted Net Income | Cost of Goods Sold Not Included |
|---|
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| ASPIRIANT DEFENSIVE ALLOCATION | 445,283 | 448,676 |
| ASPIRIANT RISK MANAGED GLOBAL | 481,751 | 556,803 |
| ASPIRIANT RISK-MANAGED TAXABLE | 360,500 | 365,574 |
| CORCEPT THERAPEUTICS INC | 1,362,289 | 1,498,854 |
| DFA EMERGING MARKETS CORE EQ P | 66,912 | 73,806 |
| DFA EMERGING MARKETS VALUE POR | 63,475 | 66,229 |
| DFA INTERNATIONAL CORE EQUITY | 157,472 | 180,746 |
| DFA INTERNATIONAL SMALL CAP VA | 76,000 | 83,619 |
| DOUBLELINE TOTAL RETURN BOND | 112,543 | 98,043 |
| ISHARES CORE US VALUE | 69,172 | 88,378 |
| METROPOLITAN WEST RETURN BOND | 194,231 | 167,499 |
| VANGUARD DIVIDEND GROWTH FD | 50,000 | 55,553 |
| VANGUARD SMALL-CAP VALUE ETF | 39,621 | 50,212 |
| VANGUARD TOTAL BOND MARKET IND | 78,091 | 69,133 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Administrative Fees | 18,421 | 18,421 | ||
| State or Local Filing Fees | 25 | 25 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Investment Management Services | 3,763 | 3,763 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 990-PF Estimated Tax for 2023 | 5,400 | |||
| 990-PF Excise Tax for 2022 | 525 |